Story
Chromium
Last updated
In one pass Chromium is a trace element the body needs in tiny amounts.
Educational content, not medical advice — consult a clinician.
Story path
Chapter 1
Trace amount
Chromium is a trace element the body needs in tiny amounts. Ordinary people almost never run short of it from food, and almost never eat their way to poisoning either. It was once sold as a blood-sugar supplement, but the evidence behind that claim did not hold up; nutrition scientists now question whether people need chromium from their diet at all.
The chromium worth worrying about is not on your plate or in a supplement bottle. Food and supplements contain trivalent chromium: the gut absorbs only a little of it, and what the body does not use leaves in the urine. The form that causes cancer is hexavalent chromium in industrial settings — from electroplating, welding fume and contaminated drinking water. So the things to watch are workplace exposure and water quality, not how much of a supplement you take.
Supplement doses are not risk-free either: there are case reports of rhabdomyolysis (the breakdown of large numbers of muscle cells) and acute kidney injury after taking chromium supplements. If you develop severe muscle pain or weakness, urine the color of strong tea, or a clear drop in how much you urinate while taking a supplement, seek medical care immediately.
The chromium worth worrying about is not on your plate or in a supplement bottle. Food and supplements contain trivalent chromium: the gut absorbs only a little of it, and what the body does not use leaves in the urine. The form that causes cancer is hexavalent chromium in industrial settings — from electroplating, welding fume and contaminated drinking water. So the things to watch are workplace exposure and water quality, not how much of a supplement you take.
Supplement doses are not risk-free either: there are case reports of rhabdomyolysis (the breakdown of large numbers of muscle cells) and acute kidney injury after taking chromium supplements. If you develop severe muscle pain or weakness, urine the color of strong tea, or a clear drop in how much you urinate while taking a supplement, seek medical care immediately.
Safety · How the two forms of chromium differ
Chromium has two common oxidation states (how many electrons the atom has given up), and their safety could hardly be more different.Trivalent chromium, Cr(III), the nutritional form:
All the chromium in food and supplements is this formAbsorption is low (< 2.5%), and it does not build up in the bodyToxicity is low: the US Institute of Medicine (IOM) found no evidence that high intakes cause harm, so it set no tolerable upper intake level (). Common supplement doses run from a few hundred up to 1000 µg/day, and so far there are only scattered case reports of adverse events (the safety chapter has the details)
Hexavalent chromium, Cr(VI), the industrial poison:
It comes from electroplating, leather tanning, pigments and stainless-steel welding, and from contaminated drinking waterThe International Agency for Research on Cancer (IARC) classifies hexavalent chromium compounds as Group 1 carcinogens, meaning the evidence that they cause cancer in people is sufficient (a grade of how certain the evidence is, not of how large the risk is). The firmest evidence is for lung cancer after inhalation; cancers of the nasal cavity and sinuses are also linked to itOn skin it is corrosive, and it can cause chromium allergy, called chromate dermatitisBackground: the Erin Brockovich case (1990s), in which the US company PG&E polluted groundwater with hexavalent chromium, was later made into a film and is a classic case in environmental toxicology
So: chromium supplements (for example chromium picolinate) contain trivalent chromium, which has low toxicity — whether they do anything is a separate question. The danger is hexavalent chromium breathed in or swallowed in industrial settings. Cooking in a stainless-steel pan releases small amounts of trivalent chromium, not hexavalent.
In practice: if you are genuinely worried about chromium, check your drinking water and your workplace exposure, not your supplement dose.
Mechanism · Why one form is harmless, one a carcinogen
Change a chemical formula a little, and something almost non-toxic becomes a Group 1 carcinogen. It sounds exaggerated, but the difference is real, and it comes down to two concrete things: whether it can get into cells, and whether it damages DNA once it is inside.Trivalent chromium, Cr(III), in food and supplements: the body barely lets it in.
In water it wears a thick shell of water molecules, which makes it bulky and slow, and there is no channel in the gut wall dedicated to moving it. As a result, almost everything you swallow never enters the body at all and leaves in the stool unchanged. The tiny fraction that is absorbed enters the blood and rides on transferrin (the protein that normally carries iron); whatever is not used is filtered by the kidneys into the urine.
No dedicated channel, no build-up, exit through the urine: stacked together, these three are why you can hardly eat your way to chromium poisoning, and also why a supplement struggles to raise the body's chromium much. The same mechanism protects you and limits what a supplement can do: swallow twice as much, and the amount that gets in does not double.
Hexavalent chromium, Cr(VI), in industry: it gets into cells easily, and it injures where it lands.
In body fluids hexavalent chromium exists as chromate, which is shaped much like sulfate, so the channels in cell membranes that carry sulfate let it in as if it belonged. Inside the cell it is reduced step by step back to the trivalent form, and the reactive intermediates made along the way damage DNA. It is also a strong oxidant, so the tissue it touches first is injured first. Its damage therefore follows a tidy pattern: the injury sits at the contact surface. On skin, that means corrosion and allergy; breathed in, it harms the lungs and nasal passages. In people exposed at work, the firmest evidence is for lung cancer, and cancers of the nasal cavity and sinuses are also linked to it.
This looks nothing like a nutrient. A nutrient is absorbed and carried by the blood through the whole body, and where it acts is decided by which protein it binds. The injury map of a contact toxicant is essentially the map of where it landed. When damage is concentrated at the points of entry, you can reasonably judge it to be contact injury, not metabolic injury.
So "is chromium safe?" is the wrong question.
Ask which chromium, and by which route it came in. The line on a supplement label is about swallowed trivalent chromium; what floats in the air of a plating shop is inhaled hexavalent chromium. Under the same chemical symbol, these are not the same discussion. Using hexavalent chromium to scare yourself off a supplement, and using chromium is an essential trace element to excuse industrial exposure, are the same mistake made in opposite directions.
Chapter 2
Why the blood-sugar claim fell apart
The claim that chromium controls blood sugar rests on a specific molecular story, and today most of that story has collapsed.
Here is the story. Insulin does not move sugar itself — not a single grain. It docks on insulin receptors on the surface of muscle and fat cells and sets off a relay of signals that runs deep into the cell. Only at the last handoff does the cell push sugar-carrying channels up to its membrane, so that sugar in the blood can flow in. Chromium was assigned a place in the middle of this relay, where it supposedly turns up a signal that is already ringing.
Notice the shape of that claim: an amplifier, not a substitute. If insulin has not rung the doorbell first, chromium has nothing to amplify; if the signal is already getting through well, more chromium buys no extra action. If the hypothesis is right, it already explains why most people see no change after taking chromium.
Worse, even the amplifier mechanism itself has not been firmly shown to happen in animals.
Here is the story. Insulin does not move sugar itself — not a single grain. It docks on insulin receptors on the surface of muscle and fat cells and sets off a relay of signals that runs deep into the cell. Only at the last handoff does the cell push sugar-carrying channels up to its membrane, so that sugar in the blood can flow in. Chromium was assigned a place in the middle of this relay, where it supposedly turns up a signal that is already ringing.
Notice the shape of that claim: an amplifier, not a substitute. If insulin has not rung the doorbell first, chromium has nothing to amplify; if the signal is already getting through well, more chromium buys no extra action. If the hypothesis is right, it already explains why most people see no change after taking chromium.
Worse, even the amplifier mechanism itself has not been firmly shown to happen in animals.
Mechanism · Where chromium sits in insulin signaling
First, tell the insulin story all the way through: chromium's role only makes sense once you can see which leg of the relay it is supposed to run.After a meal, glucose in the blood rises, and the β cells in the pancreas release insulin into the bloodstream.
What insulin does next is not what most people think: it does not move sugar itself, not a single grain. It travels to the surface of muscle and fat cells and docks on a protein called the insulin receptor. This receptor spans the cell membrane: the half exposed outside catches insulin, and the half inside the membrane is an enzyme.
Once insulin docks, the outer half changes shape, the inner half is pulled open with it, and it starts hanging phosphate groups on itself and on a string of downstream proteins. Hanging on a phosphate switches that protein on; each one switched on then switches on the next, like dominoes falling deep into the cell.
At the last handoff, the cell pushes glucose transporter proteins, which had been stored in small internal vesicles, up to the cell membrane and inserts them. Only then is the door open. Glucose in the blood flows into the cell down its concentration gradient, and blood sugar falls.
So which step was chromium assigned to?
On the chromodulin (low-molecular-weight chromium-binding substance, LMWCr) hypothesis, cells contain a very small peptide that does nothing while empty. Once loaded with chromium, it attaches to the inner side of a receptor that insulin has already pulled open and makes it add phosphates more vigorously.
In other words, chromium neither opens the door nor moves sugar. The only position this hypothesis gives it is turning up the volume of a signal that is already ringing.
That position sets its ceiling:
If insulin has not rung the doorbell first, there is nothing to amplify. So it cannot rescue the kind of diabetes in which insulin itself is missing, and it will not make the pancreas release any more insulin: it stands after insulin, not before it.In people whose signal line is already clear, the gain is already enough. More chromium buys no more downstream action. If the hypothesis is right, that is why people who are not short of chromium see no change after taking it.On this logic, the people most likely to benefit are those whose signal already struggles to get through, such as people with type 2 diabetes. Yet when randomized trials like these are pooled, fasting blood glucose does not change (Bailey 2013). The "it should work" that the mechanism predicts did not show up in people.
An analogy that teaches one thing: think of the insulin receptor as the intercom at the front door. Insulin is the person ringing the bell, the phosphate relay is the message carried into the house, and the glucose transporter is the person who finally goes to open the door. On this hypothesis, chromium is the volume knob on the side of the intercom. If the bell has not rung at all, turning the knob all the way up still gives silence; if the message was already perfectly clear, turning it up does not open another door. The analogy only shows the position; it does not show that the knob exists, which is exactly what is in dispute.
Keep this shape in mind and you can reason out neighboring cases yourself: anything described as enhancing the action of X works on some leg of the relay after X. Its ceiling is always set by X — if X does not show up, whatever it does adds up to zero. You can make that judgment before reading a single trial.
Evidence · Four places the GTF hypothesis collapsed
The supplement story starts with the Glucose Tolerance Factor (GTF) hypothesis, proposed in the mid-20th century: the idea that the body contains a chromium-bearing compound that boosts insulin-receptor activity. That story carried the chromium-supplement industry for 50 years. Today it has largely been overturned, and not in one place but in four:1. The lead actor never came on stage. For a hypothesis to stand, you at least have to isolate the key compound, purify it and see its structure. GTF has never been isolated or purified, despite 50 years of searching.
2. The early positive results may have been contamination the labs created themselves. Chromium experiments in that era used stainless-steel vessels, and stainless steel itself sheds trace chromium; the analytical methods of the time were not sensitive enough to tell whether that chromium came from the sample or from the vessel. In other words, some of the chromium that got measured may have come from the lab bench.
3. Take it away, and healthy people are fine. The test of whether a nutrient is essential is direct: remove it from the diet, and a reproducible set of symptoms should appear and then disappear when it is given back. Chromium deficiency has never been reported in healthy populations, and there are no accepted deficiency symptoms. The only near-evidence comes from a few patients on long-term total parenteral nutrition (TPN, feeding entirely by vein): decades ago, a handful of reports described high blood sugar, weight loss and nerve symptoms that improved with large doses of chromium. But those reports did not properly measure how much chromium the feeding solutions already contained, and recent evaluations conclude they do not show the patients were actually chromium-deficient (NIH ODS). This is the fatal point, because the very definition of essential hangs on it.
4. The official wording followed. The European Food Safety Authority (EFSA) concluded in 2014 that it could define neither an Average Requirement nor a Population Reference Intake (PRI) for chromium, and that setting an Adequate Intake () was not appropriate either, because no benefit of chromium intake could be seen in healthy people. The US Institute of Medicine (IOM) still keeps an AI (35 µg/day for adult men), but an AI is by definition an estimate given when the evidence is too thin to set a recommended amount, not a requirement. The two bodies are not arguing; they are saying the same thing: nobody knows how much a person needs, because no one has ever seen what lacking it looks like in a healthy person.
And the clinical trials?
Anderson 1997: a randomized, placebo-controlled trial in people with type 2 diabetes that gave chromium picolinate at 200–1000 µg/day and reported improvements in blood glucose and , more clearly in the 1000 µg/day group. It is the trial most often cited for chromium and blood sugar, but its result was not consistently repeated in later trialsBailey 2013 (*Biological Trace Element Research*): a pooled analysis of 16 randomized placebo-controlled trials with 809 people (with and without diabetes), looking at fasting blood glucose. The pooled effect size was 0.02 (p = 0.787), and the measure of disagreement between trials was I² = 0%. It is not a Cochrane review — there is no Cochrane review of chromium for type 2 diabetes at allCostello 2016 (researchers at the NIH Office of Dietary Supplements): after a systematic search of randomized trials in type 2 diabetes, only a few trials reached clinically meaningful glucose targets; the conclusion was limited effectiveness and little reason to recommend chromium for blood-sugar controlThe American Diabetes Association (ADA): judges the evidence insufficient and does not recommend routine chromium supplements for diabetes
I² = 0% is worth a second look. I² measures how much the trials disagree with one another; zero means they agree closely — on finding no effect. Scattered results would still leave room for maybe it helps some people; here, different teams, different doses and different populations all landed near the same zero. Keep in mind that the outcome was fasting glucose alone.
The last point to take in: a plausible molecular pathway between chromium and insulin signaling has been proposed (chromodulin, the LMWCr hypothesis), but the active form in the human body is still disputed, and taking chromium does not reliably improve blood sugar. It is a textbook case of a mechanism that makes sense is not a supplement that works. Calling chromium a blood-sugar switch is marketing, not medicine.
costello-2016-nutrev-chromiumada-2024-diabetes-standards
In practice · What actually moves blood sugar
If your goal is blood-sugar control, chromium supplements sit at the very bottom of the evidence. Here are the common options, grouped by the type of evidence behind them:Backed by consistent evidence from randomized trials:
A lifestyle program of weight loss plus exercise: in the Diabetes Prevention Program (DPP trial, adults with impaired glucose tolerance), the lifestyle group, whose goals were weight loss and 150 minutes of exercise a week, had a 58% lower risk of developing type 2 diabetes than the control groupEating patterns: patterns such as DASH and the Mediterranean diet improve blood-sugar control in randomized trialsRegular exercise: aerobic work plus strength training improves insulin sensitivityMetformin: the first-line drug for type 2 diabetes, with a well-established effect on (HbA1c, a measure of average blood sugar over recent months) receptor agonists (semaglutide, tirzepatide): their effects on weight and blood sugar are clear in large randomized trialsStopping smoking and limiting alcohol
Supported, but more weakly:
Enough sleep: short-term sleep loss raises fasting insulin and insulin resistance, with the evidence coming mostly from short experimentsHigh-fiber diets and probiotics: small improvements in glycated hemoglobin, and the studies do not fully agreeVitamin D and magnesium: only meaningful for people who are actually low; low magnesium is common in type 2 diabetes
Weak or no evidence:
Chromium supplements: pooled randomized trials show no change in fasting blood glucoseCinnamon: some small studies saw improvement, but disagreeBitter melon, fenugreek and tartary buckwheat: folk remedies with weak modern evidenceSingle tools such as wearing a glucose monitor or logging intermittent fasting: changing behavior helps, but one tool on its own is not enough
The key point: blood-sugar control is a whole project of lifestyle plus medication when needed, and trace nutrients like chromium do not make it into the foundation.
In practice: if you want to spend money on blood-sugar control, start with medicines your doctor prescribes (metformin, GLP-1 drugs) and with the people and places that help you change your lifestyle (a dietitian, a coach, somewhere to exercise). Next comes vitamin D or magnesium if you are actually low. Chromium supplements come last, and their effect is more psychological than physiological.
costello-2016-nutrev-chromiumdpp-2002-nejm
Chapter 3
Scattered in foods
The chromium content of food is the least reliable line on a nutrition label. It is measured in micrograms — amounts so small that knives, pans and lab vessels can add chromium on the same scale. Stainless-steel processing and cooking both release a little trivalent chromium, so older data ran high across the board, and when foods are re-measured with modern contamination-free methods, many values come out much lower.
A few commonly quoted figures (per serving, not per 100 g): cooked broccoli about 22 µg, grape juice about 8 µg, cashews about 7 µg, ham about 4 µg, whole-wheat bread about 4 µg. Treat them only as a sense of scale.
That does not change the conclusion: the requirement is tiny, and a varied whole-food diet almost certainly covers it. A meal cooked in a stainless-steel pan releases a few micrograms of trivalent chromium, which is safe.
A few commonly quoted figures (per serving, not per 100 g): cooked broccoli about 22 µg, grape juice about 8 µg, cashews about 7 µg, ham about 4 µg, whole-wheat bread about 4 µg. Treat them only as a sense of scale.
That does not change the conclusion: the requirement is tiny, and a varied whole-food diet almost certainly covers it. A meal cooked in a stainless-steel pan releases a few micrograms of trivalent chromium, which is safe.
Numbers · Why food chromium is hard to measure
Why it is hard to measure:Food chromium is measured in microgramsStainless-steel processing and cooking equipment releases chromium, so every step of processing, cooking and sample preparation can add contaminationEarly data (1970s–80s) generally overestimated how much chromium foods really containThe NIH Office of Dietary Supplements (NIH ODS) itself warns that its table of chromium in foods should serve only as a guide
Reasonably reliable sources (approximate values per serving):
Broccoli (cooked): ~22 µgGrape juice: ~8 µgCashews: ~7 µgHam: ~4 µgWhole-wheat bread: ~4 µg
Reference intakes: the US IOM set an Adequate Intake () of 35 µg/day for adult men and 25 µg/day for adult women; the European Food Safety Authority (EFSA) set no reference intake for chromium at all in 2014 and judged that even an AI was not appropriate.
In practice:
A varied whole-food diet almost certainly meets this tiny needCounting exactly how much chromium you ate each day is not realistic, because the underlying data are not accurateNo special attention is needed: this is one of the trace elements you have the least reason to worry about
An irony: cooking in stainless-steel pans really does release trace chromium (a few micrograms per meal), but it is trivalent chromium and safe. So stainless-steel cookware may itself be the biggest dietary chromium supplement most people get — and nobody mentions it.
Mechanism · Why this column is born inaccurate
Why a chromium table is inaccurate from birth: this is worth telling separately, because the lesson carries over to any nutrition table.Trace-element measurement has a problem of its own: the amount you are trying to measure is the same order of magnitude as what your vessels, knives and blender can contribute.
Measuring iron or zinc does not suffer from this: the sample's own content is far larger than anything contamination can add, and the noise drowns in the signal. Chromium is different: a few cuts with a stainless-steel knife can drop as much chromium onto a vegetable as the vegetable itself contains. So those early high values were not, strictly speaking, measured wrong — they measured the laboratory itself.
The modern practice is to remove metal from the whole chain: plastic or quartz vessels throughout, ultrapure reagents, a clean bench. After that switch, values for the same foods drop sharply, which is how the old data came to be systematically too high. It is also why the chromium column in food-composition databases is updated more slowly than others: measuring again costs far more than recalculating.
The rule you can take away: how reliable a nutrition number is depends on how far its magnitude sits from the measurement noise.
Gram-scale macronutrients (protein, fat, carbohydrate): stable enough to keep accounts withMilligram-scale major minerals (calcium, potassium): still reasonableMicrogram-scale trace elements (chromium is among the hardest to measure): the number in the table is more an order-of-magnitude guide than an account you can add up line by line
So the question did I get enough chromium today? has no answerable form. It is not that nobody is willing to do the sum; the source data cannot support that precision.
And this does not change the conclusion: the requirement is so tiny that a varied whole-food diet is almost bound to clear it. You do not need an accurate table to know you are not short — the two never depended on each other.
Chapter 4
Evidence does not support supplements
Put chromium supplements in the line-up of evidence for blood-sugar control, and they sit at the very end: pooled randomized trials show no change in fasting blood glucose, which puts chromium in the weakest layer alongside folk remedies such as cinnamon, bitter melon and fenugreek.
Why does the market still sell it? The blood-sugar label appeals strongly to buyers; weak evidence is not the same as disproof, and no single study settles that it is harmful; and with a low price and low toxicity, sellers take almost no risk.
How to spend blood-sugar money instead: first, medicines your doctor prescribes (metformin, drugs) and the dietitians, coaches and places to exercise that help you change your lifestyle; next, vitamin D or magnesium if you are actually low. Chromium supplements offer little beyond reassurance. The same money spent on vegetables, fruit, exercise and sleep returns far more than chromium supplements do.
Why does the market still sell it? The blood-sugar label appeals strongly to buyers; weak evidence is not the same as disproof, and no single study settles that it is harmful; and with a low price and low toxicity, sellers take almost no risk.
How to spend blood-sugar money instead: first, medicines your doctor prescribes (metformin, drugs) and the dietitians, coaches and places to exercise that help you change your lifestyle; next, vitamin D or magnesium if you are actually low. Chromium supplements offer little beyond reassurance. The same money spent on vegetables, fruit, exercise and sleep returns far more than chromium supplements do.
Myth · Why chromium pills still sell
The Glucose Tolerance Factor (GTF) is a hypothesis from the mid-20th century: that the body contains a chromium-bearing compound that boosts insulin-receptor activity. For decades it held up the entire chromium-supplement industry. Today it has largely been overturned. The chapter on why the chromium blood-sugar claim fell apart sets out the reasons one by one; here are only the conclusions:GTF has never been isolated or purified, despite 50 years of searchingSince the 2000s, more and more evidence has shown that the claim chromium is an essential human nutrient does not stand: chromium deficiency has never been reported in healthy populations (Vincent 2017)Early experimental results may reflect measurement contamination: chromium leaching from stainless-steel vessels, and analytical methods of the time that were not sensitive enoughThe European Food Safety Authority (EFSA) set no reference intake for chromium in 2014 and judged that even an Adequate Intake () was not appropriateThe US IOM still keeps an AI of 25–35 µg/day, but an AI is an estimate made when evidence is thin, not a requirement
Randomized trials on blood sugar:
Anderson 1997: people with type 2 diabetes given chromium picolinate at 200–1000 µg/day showed improved blood glucose, a result that was not consistently repeated laterBailey 2013 (*Biological Trace Element Research*, 16 randomized trials, 809 people): the pooled effect on fasting blood glucose was 0.02, p = 0.787, I² = 0% — the trials agree there is no effect. It is not a Cochrane review; there is no Cochrane review of chromium for type 2 diabetes at allCostello 2016 (researchers at the NIH Office of Dietary Supplements): limited effectiveness, little reason to recommend it for blood-sugar controlThe American Diabetes Association (ADA): the evidence is insufficient, and routine use is not recommended
Why it still sells:
The blood-sugar control label appeals strongly to buyersWeak evidence is not disproof: no single study settles that it is harmfulLow price and low toxicity mean low commercial risk
In practice:
Do not count on chromium supplements to control blood sugar or help you lose weightWhat works for weight and blood sugar is an eating pattern (DASH, the Mediterranean diet, a diet low on the glycemic index, or ), exercise (aerobic plus strength training), sleep, and, when needed, medicines your doctor prescribes (metformin, drugs)Chromium supplements: no evidence-based role, and not dangerous either; but money spent on them will most likely buy no effect
costello-2016-nutrev-chromiumada-2024-diabetes-standards
Myth · Three questions for any supplement ad
The most useful thing to take away from chromium is not the conclusion don't buy chromium, but the way of judging that it demonstrates — one you can use again and again.The sentence supplement ads love most is X is involved in Y. It is usually true — true enough that you can look up the pathway in a textbook. But it is still three steps away from taking X improves Y, and each step can break:
1. Does this chain actually hold in living people?
Results from cells in a dish or from rats may not survive the move to humans. Chromium is stuck at exactly this step: the key chromium-bearing compound has been sought for half a century and has never been produced.
2. In your body, is this chain stuck right now because you lack X?
Even if the chain is real, adding more only helps when X happens to be the current bottleneck. Adding a lane to a road that is not jammed does not make traffic move faster. Chromium fails this step most thoroughly: almost nobody is short of it, so for almost everyone it is not the bottleneck at all.
3. Does the amount you swallow actually reach that step?
Absorption, transport and metabolism each take their cut. For something that does not even have a dedicated channel in the gut wall, more than time stands between your mouth and that step inside the cell.
Only when all three questions pass do you get to ask is there a trial that measured the outcome that matters? Chromium is disputed on question 1, and for the vast majority of people question 2 simply fails — so you do not need to read that pile of trials to predict the result will land near zero. The later only confirmed the prediction.
This checklist is most useful when you cannot find the evidence. Ads can always cite more mechanism papers than outcome trials, because mechanism studies are cheap and trials are expensive. Put the other way: a pitch that talks only about mechanism and never about outcomes usually does so because the outcome column is empty.
Keep these three questions, and the next time you read something like "so-and-so is involved in energy metabolism" or "so-and-so supports immune function", you will not stop at sounds reasonable — you will go straight to question 2: am I actually short of it?
Chapter 5
Caution groups
Chromium supplements have low toxicity overall, but low is not zero. A few case reports mark the edge:
Rhabdomyolysis (breakdown of large numbers of muscle cells): a 24-year-old bodybuilder became ill after taking a total of 1200 µg of chromium picolinate within 48 hours (Martin 1998; note that this is a two-day total, not a daily dose)Acute kidney injury: a 24-year-old man with only one kidney developed acute tubular necrosis after 2 weeks of a multi-ingredient workout supplement containing chromium (Wani 2006; the paper gives no chromium dose)
If you develop severe muscle pain or weakness, urine the color of strong tea, or a clear drop in how much you urinate while taking a supplement, seek medical care immediately.
People who should be more cautious: those with chronic kidney disease () stage 3 or higher, people taking diabetes medicines, people with a history of chromium allergy, and pregnant women. The most practical advice: do not spend money on chromium supplements.
Rhabdomyolysis (breakdown of large numbers of muscle cells): a 24-year-old bodybuilder became ill after taking a total of 1200 µg of chromium picolinate within 48 hours (Martin 1998; note that this is a two-day total, not a daily dose)Acute kidney injury: a 24-year-old man with only one kidney developed acute tubular necrosis after 2 weeks of a multi-ingredient workout supplement containing chromium (Wani 2006; the paper gives no chromium dose)
If you develop severe muscle pain or weakness, urine the color of strong tea, or a clear drop in how much you urinate while taking a supplement, seek medical care immediately.
People who should be more cautious: those with chronic kidney disease () stage 3 or higher, people taking diabetes medicines, people with a history of chromium allergy, and pregnant women. The most practical advice: do not spend money on chromium supplements.
Safety · Documented harms from chromium pills
Chromium supplements have low toxicity overall, but real case reports remind us that low toxicity is not the same as no risk.Rare but documented adverse events:
Rhabdomyolysis (Martin 1998, a single case): a 24-year-old bodybuilder became ill after taking a total of 1200 µg of chromium picolinate within 48 hoursAcute tubular necrosis (Wani 2006, a single case): a 24-year-old man with only one kidney became ill after two weeks of a multi-ingredient supplement containing chromiumScattered case reports compiled by the NIH Office of Dietary Supplements (NIH ODS) also include weight loss, anemia, low platelets, abnormal liver function, low blood sugar and dermatitisContact dermatitis: in people allergic to chromiumDNA damage: in laboratory experiments, high concentrations of trivalent chromium can also oxidize DNA; whether this happens at normal supplement doses is not knownInteractions with diabetes medicines: taken with insulin, metformin or sulfonylureas, chromium could in theory add to the risk of low blood sugar
People who should be more cautious:
stage 3 or higher: chromium leaves through the kidneys, so excretion is reduced; the US IOM also noted that people with kidney or liver disease may be more susceptible to high dosesPeople taking diabetes medicines: the risk of low blood sugar may add upPeople with a history of chromium allergy (chromate dermatitis): taking it by mouth may make the rash worsePregnancy: data are lacking, so it is not recommended
Putting the real risks side by side:
Chromium supplements: low risk, and a weak effectNo supplement, and a better eating pattern: none of that risk, and a far better effect
The most honest advice: do not spend money on chromium. The same money spent on vegetables, fruit, exercise and sleep returns far more than chromium supplements do.
Evidence · What a case report can and cannot show
How should the two cases, Martin 1998 and Wani 2006, be read?A case report is the weakest link in the chain of evidence. It describes what happened to one person: no control group, no random assignment, no way to rule out coincidence. One person took chromium, trained at the gym and then developed rhabdomyolysis — from that alone you cannot tell whether the chromium did it, the training did it, or the two happened to collide.
But it can do one thing a controlled trial cannot: detect rare, unexpected events. A trial that enrolls a few hundred people for a few months is built in a way that cannot catch very rare events: it lacks the statistical power, and such events simply do not show up in the sample. A case report needs no statistical power, only someone who notices and writes it down.
So the right way to read a case report is as a searchlight at the edge, not a table of risk probabilities. Those two cases tell you this has happened, not how likely you are to run into it if you take chromium. Conversely, when someone uses one or two cases to frighten or persuade you, they are using a searchlight as a probability table.
Look at it from the other side and it makes sense. Chromium supplements have sat quietly on shelves for decades precisely because so few events in that time were worth writing up as case reports. The low risk is real. But low risk does not make something worth buying: that depends on a different column, and in the effect column, pooled randomized trials have already given an answer close to zero.
One last rule to take away: what the two cases share is taking chromium as a supplement, not staying at the amounts food provides. That is no coincidence. With something almost inert at dietary doses, problems tend to appear at the end where it is taken like a drug: you push intake to heights food never reaches, and in doing so you leave the range where safety at that dose has actually been observed.
And what you get in return for that risk is a benefit close to zero. That is the real reason to walk away — not that it is dangerous, but that it is not worth it.
References · 7
- National Institutes of Health, Office of Dietary Supplements. (2022). Chromium — Fact Sheet for Health Professionals. Fact sheet (updated June 2, 2022; Wayback snapshot 18 September 2026): Table 2 values are per serving (e.g. grape juice, 1 cup, 7.5 mcg; ham, 3 ounces, 3.6 mcg); chromium in foods varies widely with local soil, water and processing, so the table should only serve as a guide (fact sheet). ods.od.nih.gov/factsheets/Chromium-HealthProfessional
- Anderson, R. A., Cheng, N., Bryden, N. A., Polansky, M. M., Cheng, N., Chi, J., & Feng, J. (1997). Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes, 46(11), 1786–1791. 10.2337/diab.46.11.1786
- Vincent, J. B. (2017). New evidence against chromium as an essential trace element. The Journal of Nutrition, 147(12), 2212–2219. 10.3945/jn.117.255901
- EFSA Panel on Dietetic Products, Nutrition and Allergies. (2014). Scientific Opinion on Dietary Reference Values for chromium. EFSA Journal, 12(10), 3845. Panel conclusion: an essential function of Cr(III) has not been substantiated; no Average Requirement and no Population Reference Intake for chromium can be defined; there is no evidence of beneficial effects of chromium intake in healthy subjects; setting an Adequate Intake is also not appropriate (abstract, via Crossref). 10.2903/j.efsa.2014.3845
- Wani, S., Weskamp, C., Marple, J., Spry, L. (2006). Acute Tubular Necrosis Associated with Chromium Picolinate–Containing Dietary Supplement. Annals of Pharmacotherapy, 40(3), 563-566. A single case report: a 24-year-old man with a solitary kidney developed acute tubular necrosis after TWO WEEKS of a multi-ingredient workout supplement. It states no chromium dose, and the histology is tubular necrosis, not interstitial nephritis. The story used to print 600 microg/day for 6 months and interstitial nephritis. 10.1345/aph.1G469
- Bailey, C. H. (2013). Improved Meta-Analytic Methods Show No Effect of Chromium Supplements on Fasting Glucose. Biological Trace Element Research, 157(1), 1-8. Biological Trace Element Research, not Cochrane — there is no Cochrane review of chromium for type 2 diabetes at all. 16 RCTs, 809 participants, effect size 0.02, p = 0.787, and I-squared = 0%: the trials AGREE that there is no effect. The story used to say 28 RCTs with large heterogeneity, which inverts the meaning. Abstract detail: outcome fasting glucose; 16 placebo-controlled RCTs with 440 people with diabetes and 369 without; no effect in either group; fixed-effect model because I-squared = 0% (abstract, PMID 24293356; PubMed dates the issue 2014). 10.1007/s12011-013-9863-9
- Martin, W. R., Fuller, R. E. (1998). Suspected Chromium Picolinate-Induced Rhabdomyolysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 18(4), 860-862. A 24-year-old bodybuilder who took 1200 microg of chromium picolinate OVER 48 HOURS — the exposure window is the point, and the story used to drop it. 10.1002/j.1875-9114.1998.tb03910.x